- Home
- Events
- Formulation Strategies...
- Event Overview
Registration
Download Brochure
Event Information
Add to Outlook Calendar
Related Events
-
October 08-12, 2012
-
October 11-12, 2012
Find Another IBC Event
Formulation Strategies for Protein Therapeutics
CSS
A Must Attend Conference for Protein Formulators
October 09-10, 2012 · Rhode Island Convention Center · Providence, RI
Event Overview
Event Overview
Register by June 22 and Save $500 off the standard rates
Deadline: March 16
» Submit your proposal
Join our priority contact list and receive the latest event news.
IBC's 11th annual Formulation Strategies for Protein Therapeutics was again a must-attend conference for the global community of formulation, delivery and analytical development scientists from biotherapeutic development organizations.
Twenty-eight case studies were presented at this year's conference, offering practical solutions to the most pressing day to day challenges in formulation development for therapeutic proteins. These were combined with presentations on cutting edge protein science from leading academics and briefings on strategic issues of importance to this important field.
Formulation Strategies was co-located with the BioProcess International™ Conference and Exhibition, offering attendees the opportunity to visit with more than 150 suppliers of bioprocess technology and services and network with over 1,400 industry leaders in attendance.
We look forward to seeing you at the 12th annual conference, now scheduled for October 9-11, 2012 at the Rhode Island Convention Center in beautiful Providence.
Hear what past attendees had to say....
"Great job on the planning and execution of conference. Very helpful, also great to meet people in the field." - Jonathan Clapper, Senior Research Associate, Process Development, Trubion
"The Formulation Strategies conferences provided a comprehensive road map to state of the art formulation opportunities and challenges. It provided a snapshot of the latest industry challenges and methods to address these challenges." - David Hile, Senior Scientist, Formulation Development, Stryker Biotech
"The IBC conference is a unique opportunity to get an overview of the latest developments in protein formulation with the technical experts from the biotech industry" - Sylvan Huille, Department Head, Formulation Development, LFB France
"Case studies and specific examples are most helpful to the formula scientist for benchmarking purposes. I appreciated the high number of such presentations at this conference. The interactive breakout sessions were beneficial as well for benchmarking purposes" - Susan Martin, Senior Principal Scientist, Biologics PGRD, Pfizer
"I commend the IBC staff for putting together a balanced mix of topics including emerging areas in biotherapeutics formulation development and a problem solving session." - Tapan Das, Ph.D., Senior Principal Scientist, Pfizer Global Biologics
"The conference is a good learning experience for formulation starters - it is excellent overview for starter companies." - Harold Backus, Manager, Analytical Development, Crucell, The Netherlands
"The conference had outstanding presentations and good discussions. The round table and panel discussions are very useful." - Nazila Miller, Scientist, PAD, Shire Human Genetic Therapies
"I came to this conference as a relative novice in the formulation field. It was helpful and educational to have topics that were general as well as case studies, to highlight real world problems encountered by formulations researchers."
"IBC's annual Formulation Conference is an excellent venue to get up-to-date on the latest issues and solutions to common industry challenges." - Bernardo Perez-RamÃrez, MSc, Ph.D., Senior Scientific Director, BioFormulations Development, Genzyme Corporation